Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-15

Clinical Trial Update: Evaluating the Effects of Tasimelteon vs. Placebo on Jet Lag Type Insomnia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating tasimelteon versus placebo for jet lag type insomnia has completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tasimelteon (tasimelteon)

Snippet

Sponsor: Vanda Pharmaceuticals | Conditions: Jet Lag Type Insomnia | Phase 3 | Status: COMPLETED | Results posted: 2023-09-15